ABBV vs EOLS · P/E 81, rev $61.16B vs rev $266.3M
AbbVie Inc (ABBV) versus Evolus Inc (EOLS) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Evolus Inc (EOLS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported EOLS revenue for 2024-12-31 was $266.3M. Net income was -$50.4M. Revenue was up 31.8% from 2023-12-31 to 2024-12-31. EOLS currently screens at market cap $597.0M.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. EOLS currently screens at market cap $597.0M.
Not investment advice. Open the ABBV and EOLS stock pages for the full models.
Not investment advice.